Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) | September 8, 2005 | |
Targeted Genetics Corporation
Washington | 0-23930 | 91-1549568 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
1100 Olive Way, Suite 100, Seattle, Washington | 98101 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code | (206) 623-7612 | |
Not Applicable
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 5.02.Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. | ||||||||
SIGNATURES |
Table of Contents
Item 5.02.Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On September 8, 2005, Mr. Mark H. Richmond, age 74, notified Targeted Genetics of his decision to retire from his position as a board member effective October 31, 2005. Mr. Richmond’s retirement from the Targeted Genetics board, follows his retirement from other boards on which he served.
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Targeted Genetics Corporation | ||||
By: | /s/Todd E. Simpson | |||
Todd E. Simpson | ||||
Vice President, Finance and Administration and Chief Financial Officer, Secretary and Treasurer (Principal Financial and Accounting Officer) | ||||
Dated: September 13, 2005
3